| Jessica Anne Wilkinson, MOTR/L | |
|
1300 Mcgee Dr Ste 113, Norman, OK 73072-5858 | |
| (405) 535-3888 | |
| (405) 366-0010 |
| Full Name | Jessica Anne Wilkinson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1300 Mcgee Dr Ste 113, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902153281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 1782 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Anne Wilkinson, MOTR/L 1300 Mcgee Dr Ste 113, Norman, OK 73072-5858 Ph: (405) 535-3888 | Jessica Anne Wilkinson, MOTR/L 1300 Mcgee Dr Ste 113, Norman, OK 73072-5858 Ph: (405) 535-3888 |
News Archive
As the newest statistics from the CDC show, diabetes is an ever increasing problem for Americans. Almost 26 million adults in this country now have diabetes, an increase of 9% since 2008. Ninety to 95% of cases are type 2 diabetes, marked by a gradual inability of the body's cells to respond to insulin, and eventually an inability to produce enough insulin. In addition, almost 79 million people in this country have prediabetes. The CDC has warned that if diabetes continues on its current course, it could affect a third of all adult Americans by 2050.
Two experimental antiretroviral drugs, called TMC278 and elvitegravir, show promise in controlling the viral loads of HIV-positive people who have developed resistance to available drugs, researchers said Wednesday at the 14th Annual Conference on Retroviruses and Opportunistic Infections in Los Angeles, the Los Angeles Times reports.
Bayer HealthCare Pharmaceuticals Inc. today announced its official U.S. launch. The new company incorporates the former Berlex Inc.into Bayer HealthCare Pharmaceuticals, as part of Bayer's acquisition of Schering AG, Germany, Berlex's former parent company.
Incyte Corporation announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) for the design of a pivotal Phase III trial for its JAK1 and JAK2 inhibitor, INCB18424 in patients with polycythemia vera (PV), a blood cancer that belongs to a group of diseases known as myeloproliferative neoplasms (MPNs).
› Verified 1 days ago
Ms. Deanna Hewett Elias, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1250 N Interstate Dr, Norman, OK 73072 Phone: 405-573-0121 Fax: 405-573-0124 | |
Ms. Sherryl Marianne Sweeney, OT L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 330 W Gray St, Suite 100-2, Norman, OK 73069 Phone: 405-360-5552 | |
Rachel Shepherd, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2002 E Robinson St, Norman, OK 73071 Phone: 405-307-2800 Fax: 405-307-2801 | |
Amanda Wynn, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-3833 | |
Jessica Klemme, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Lindsey St Ste C-248, Norman, OK 73069 Phone: 405-360-5554 Fax: 405-360-1344 | |
Unlimited Potential Pediatrics Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 111 24th Ave Nw Ste 100, Norman, OK 73069 Phone: 580-402-3373 | |
Rachel Anne Holland, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Boyd St, Norman, OK 73069 Phone: 405-366-7898 |